Anthem Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Audited Standalone and ....
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anthem Biosciences Ltd has informed exchanges that its Board meeting is scheduled for May 19, 2026 to consider and approve the Audited Standalone and Consolidated Financial Results for Q4 and the financial year ended March 31, 2026. The Board will also consider recommending a final dividend for FY 2025-26. The trading window for insiders has been closed from April 1, 2026 and will reopen 48 hours after the results are declared. This is a routine regulatory intimation under SEBI listing regulations and does not contain any actual financial figures or audit opinions.
This is a standard pre-result announcement notice with no material new information. The actual impact on the stock will depend on the financial results and dividend recommendation when announced after May 19, 2026.